Search

Search Constraints

You searched for: Author/Creator Rusconi, Stefano

Search Results

1. 30-day mortality in patients hospitalized with COVID-19 during the first wave of the Italian epidemic: A prospective cohort study. (August 2020)

2. 96-week results of a dual therapy with darunavir/ritonavir plus rilpivirine once a day vs triple therapy in patients with suppressed viraemia: virological success and non-HIV related morbidity evaluation. Issue 1 (2nd January 2020)

3. A Comparison between two Dolutegravir-Based two-drug Regimens as Switch Strategies in a Multicentre Cohort of HIV-1-Infected Patients. Issue 1 (January 2019)

5. Accessibility to SARS-CoV-2 swab test during the Covid-19 pandemic: Did age make the difference?. Issue 12 (December 2021)

6. Atazanavir/ritonavir monotherapy: 96 week efficacy, safety and bone mineral density from the MODAt randomized trial. (5th March 2016)

7. Atazanavir/ritonavir with lamivudine as maintenance therapy in virologically suppressed HIV-infected patients: 96 week outcomes of a randomized trial. (12th April 2018)

8. Circulating endothelial progenitors are increased in COVID‐19 patients and correlate with SARS‐CoV‐2 RNA in severe cases. (31st August 2020)

9. Clinical and genetic determinants of nevirapine plasma trough concentration. (5th June 2018)